Connection
Anna Radominska-Pandya to Cannabinoid Receptor Agonists
This is a "connection" page, showing publications Anna Radominska-Pandya has written about Cannabinoid Receptor Agonists.
|
|
Connection Strength |
|
 |
|
 |
|
0.061 |
|
|
|
-
Ford BM, Franks LN, Radominska-Pandya A, Prather PL. Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development. PLoS One. 2016; 11(12):e0167240.
Score: 0.034
-
Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to ?(9)-THC: mechanism underlying greater toxicity? Life Sci. 2014 Feb 27; 97(1):45-54.
Score: 0.027